Detection of Rare Nonsynonymous Variants in TGFB1 in Otosclerosis Patients

Authors


*Corresponding author: Guy Van Camp, Dept. of Medical Genetics, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. Tel: +323 820 2491; Fax: +323 820 2566. E-mail: guy.vancamp@ua.ac.be

Summary

Otosclerosis is one of the most common forms of hearing loss in the European population. We have identified a SNP in the TGFB1 (transforming growth factor beta 1) gene that is associated with susceptibility to otosclerosis. The protective allele of this variant, with isoleucine at position 263 of the protein, is more biologically active than the risk allele, which has a threonine in this position. Because recent studies have shown that not only common, but also rare variants can be involved in complex diseases, we performed DNA sequence analysis of the exons and intron-exon boundaries of TGFB1 in 755 otosclerosis patients and 877 control samples. We found 3 different nonsynonymous variants (E29, A29 and I241) in four otosclerosis patients, but no such changes were found in controls. In silico analysis shows that these variations could influence TGF-β1 function and activity. Taking into account that most rare missense alleles are thought to have a biological effect, the data suggest that multiple rare amino acid changing variants in TGF-β1 may contribute to susceptibility to otosclerosis.

Ancillary